FdaApplication
NDA 021087
Identifiers
- fda_app_no: NDA021087
Properties
| Property | Value |
|---|---|
| applicant_name | HOFFMANN LA ROCHE INC |
| application_type | NDA |
| approval_date | 1999-10-27 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TAMIFLU | OSELTAMIVIR PHOSPHATE | EQ 75MG BASE | CAPSULE;ORAL |
| TAMIFLU | OSELTAMIVIR PHOSPHATE | EQ 45MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE;ORAL |
| TAMIFLU | OSELTAMIVIR PHOSPHATE | EQ 30MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE;ORAL |
3 products